Cosacthen vet.

1 x 1 ml

Liquid for injection, solution

Active substance

Tetracosactide (Tetracosactide hexaacetate) : 0,25 mg/ml

ATC code

QH01AA02 Tetracosactide

QH01AA ACTH

QH01A Anterior pituitary lobe hormones and analogues

QH01 Pituitary, hypothalamic hormones and analogues

QH Systemic hormonal preparations, excl. sex hormones and insulins

Species

Dogs.

Indications

For the evaluation of adrenocortical function in dogs.

Dose to be administered and administration route

Intravenous or intramuscular use.

Administer 5 µg/kg (0.02 ml/kg) by intravenous or intramuscular injection, with the purpose of performing the ACTH stimulation test. Take the first blood sample immediately prior to administering the veterinary medicinal product, and take the second blood sample between 60 and 90 minutes after administration of the veterinary medicinal product, to assess the cortisol response.

To ensure a correct dosage, body weight should be determined as accurately as possible.

Adverse reactions

Dogs:

Common

(1 to 10 animals / 100 animals treated):

Vomiting

Uncommon

(1 to 10 animals / 1,000 animals treated):

Injection site bruising^a, Injection site haematoma^b

Depression

Diarrhoea

Lameness

Nervousness

^aAfter intramuscular administration. ^bAfter intravenous administration.

Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.